Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,910 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K. Sasaki H, et al. Among authors: endo k. J Atheroscler Thromb. 2009 Oct;16(5):568-75. doi: 10.5551/jat.1628. Epub 2009 Sep 14. J Atheroscler Thromb. 2009. PMID: 19749494 Free article. Clinical Trial.
Probucol delays progression of diabetic nephropathy.
Endo K, Miyashita Y, Sasaki H, Ohira M, Saiki A, Koide N, Otsuka M, Oyama T, Takeyoshi M, Ito Y, Shirai K. Endo K, et al. Diabetes Res Clin Pract. 2006 Feb;71(2):156-63. doi: 10.1016/j.diabres.2005.05.012. Epub 2005 Jul 11. Diabetes Res Clin Pract. 2006. PMID: 16009446 Clinical Trial.
Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension.
Miyashita Y, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K. Miyashita Y, et al. Among authors: endo k. J Atheroscler Thromb. 2009 Oct;16(5):621-6. doi: 10.5551/jat.497. J Atheroscler Thromb. 2009. PMID: 19907103 Free article. Clinical Trial.
Probucol suppresses initiation of chronic hemodialysis therapy and renal dysfunction-related death in diabetic nephropathy patients: Sakura study.
Endo K, Saiki A, Yamaguchi T, Sakuma K, Sasaki H, Ban N, Kawana H, Nagayama D, Nagumo A, Ohira M, Oyama T, Murano T, Miyashita Y, Yamamura S, Suzuki Y, Shirai K, Tatsuno I. Endo K, et al. J Atheroscler Thromb. 2013;20(5):494-502. doi: 10.5551/jat.15263. Epub 2013 Jan 30. J Atheroscler Thromb. 2013. PMID: 23363981 Free article. Clinical Trial.
2,910 results